Yanis Boumber – Grants — Northwestern Scholars

View Scopus Profile

Emailyanis.boumbernorthwesternedu

h-index
h10-index
h5-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Finished
5 Active

5 results

Filter

Active

Prot #AN2025H0301: The BURAN Study of Buparlisib (AN2025) In Combination with Paclitaxel Compared to Paclitaxel Alone, in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Boumber, Y.
INC Research, LLC, Adlai Nortye USA Inc.
8/11/21 → 8/11/24
Project: Research project
Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer
Boumber, Y.
National Cancer Institute
4/1/20 → 3/31/23
Project: Research project
Prot #Ad-p53-002: A Phase 2, Multi-Center, Open Label Study to Evaluate Efficacy and Safety of Adenoviral p53 (Ad-p53) in Combination with Immune Checkpoint Inhibitor Therapy in Patients with Progression or Recurrence of Head and Neck Squamous Cell Carcin
Boumber, Y.
MultiVir Inc.
11/22/19 → 11/22/22
Project: Research project
Prot #C-145-03: A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-145) for the Treatment of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Boumber, Y.
Chiltern International, Inc., Iovance Biotherapeutics, Inc.
2/23/18 → 2/23/23
Project: Research project
Prot #MK-3475-122: A Two-Arm, Open-label, Randomized Phase II Study of Pembrolizumab (MK-3475) Monotherapy Versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (Keynote-122)
Boumber, Y. & Matsangou, M.
Merck Sharp & Dohme Corporation
1/26/17 → 1/31/25
Project: Research project